Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Evolution of the SARS‐CoV‐2 omicron variants BA. 1 to BA. 5: implications for immune escape and transmission
The first dominant SARS‐CoV‐2 Omicron variant BA. 1 harbours 35 mutations in its Spike
protein from the original SARS‐CoV‐2 variant that emerged late 2019. Soon after its …
protein from the original SARS‐CoV‐2 variant that emerged late 2019. Soon after its …
COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection
Abstract Coronavirus Disease 2019 (COVID-19) has been the most severe public health
challenge in this century. Two years after its emergence, the rapid development and …
challenge in this century. Two years after its emergence, the rapid development and …
Bivalent omicron BA. 1–adapted BNT162b2 booster in adults older than 55 years
P Winokur, J Gayed, D Fitz-Patrick… - … England Journal of …, 2023 - Mass Medical Soc
Background The emergence of immune-escape variants of severe acute respiratory
syndrome coronavirus 2 warrants the use of sequence-adapted vaccines to provide …
syndrome coronavirus 2 warrants the use of sequence-adapted vaccines to provide …
Covid-19 vaccines—immunity, variants, boosters
DH Barouch - New England Journal of Medicine, 2022 - Mass Medical Soc
Covid-19 Vaccines — Immunity, Variants, Boosters | New England Journal of Medicine Skip to
main content The New England Journal of Medicine homepage Advanced Search SEARCH …
main content The New England Journal of Medicine homepage Advanced Search SEARCH …
[HTML][HTML] Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV …
Background Few data exist on the comparative safety and immunogenicity of different
COVID-19 vaccines given as a third (booster) dose. To generate data to optimise selection …
COVID-19 vaccines given as a third (booster) dose. To generate data to optimise selection …
T cell immunity to COVID-19 vaccines
The development of multiple COVID-19 vaccines in record time is a major biomedical
achievement, but mechanistic immune correlates of vaccine protection remain to be …
achievement, but mechanistic immune correlates of vaccine protection remain to be …
Seasonal trends in COVID-19 cases, hospitalizations, and mortality in the United States and Europe
Determining whether SARS-CoV-2 exhibits seasonality like other respiratory viruses is
critical for public health planning. We evaluated whether COVID-19 rates follow a seasonal …
critical for public health planning. We evaluated whether COVID-19 rates follow a seasonal …
CD8 T cells contribute to vaccine protection against SARS-CoV-2 in macaques
Spike-specific neutralizing antibodies (NAbs) are generally considered key correlates of
vaccine protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
vaccine protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years
The rapid emergence of the B. 1.1. 529 (Omicron) variant of SARS-CoV-2 led to a global
resurgence of coronavirus disease 2019 (COVID-19). Israeli authorities approved a fourth …
resurgence of coronavirus disease 2019 (COVID-19). Israeli authorities approved a fourth …
[HTML][HTML] Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions
COVID-19 is a worldwide pandemic caused by SARS-coronavirus-2 (SARS-CoV-2). Less
than a year after the emergence of the Covid-19 pandemic, many vaccines have arrived on …
than a year after the emergence of the Covid-19 pandemic, many vaccines have arrived on …